Featured News
When Allen Schnitzerling was diagnosed with Merkel cell carcinoma, his prognosis was dire. But after putting his faith in his doctors and their “special soup”, as he affectionally calls it, Allen is now planning adventurous holidays with his wife.
When Lisa, Jenny and Vikki immigrated to Australia in their younger years, they had no idea that the outdoor lifestyle they embraced would lead to a melanoma diagnosis later in life.
Stuart is a participant in the Melanoma Margins Trial
Melanoma and Skin Cancer Trials and the Victorian Heart Institute are leading an Australian-first trial to determine if a common cholesterol medication can reduce the risk of heart attacks in melanoma patients treated with cancer therapy.
A $110,000 donation to a new trial treating melanoma brain metastases will help open additional research sites around Australia, offering hope to patients, like Peter Wilson, who have melanoma that has spread to the brain.
MASC Trials, MSCAN and BlazeAid have partnered to deliver sun safety educational videos for BlazeAid volunteers so they know how to protect their skin during frontline disaster response work.
John, who has Merkel cell carcinoma, is participating in the I-MAT trial.
Digital photography combined with artificial intelligence technology has shown promising results as a diagnostic tool for the early detection of melanoma.
A lived experience with cancer inspired Paul White and Mary Tsouvalakis to join the MASC Trials Board.
Originally diagnosed with a detached retina, a scan later revealed that Jess actually had ocular melanoma.